In the Pumwani cohort, specific polymorphisms in IRF1 were shown to result in reduced IFNγ-stimulated IRF-1 protein expression and were associated with resistance to infection [44], but not altered disease progression [45], suggesting that the protective effect is limited to early events in HIV infection. Here, IRF1 is linked to HIV infectious disease.